Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer_journal/epidemiology-biology-and-treatment-of-sarcomatoid-rcc-current-state-of-d68SIB7BoF
References (68)
-
F. Kunath, S. Schmidt, L. Krabbe, A. Miernik, P. Dahm, A. Cleves, M. Walther, N. Kroeger (2017)
Partial nephrectomy versus radical nephrectomy for clinical localised renal masses.The Cochrane database of systematic reviews, 5
-
N. Haas, J. Manola, R. Uzzo, K. Flaherty, C. Wood, C. Kane, M. Jewett, J. Dutcher, M. Atkins, M. Pins, G. Wilding, D. Cella, L. Wagner, S. Matin, T. Kuzel, W. Sexton, Y. Wong, T. Choueiri, R. Pili, I. Puzanov, M. Kohli, W. Stadler, M. Carducci, R. Coomes, R. DiPaola (2016)
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trialThe Lancet, 387
-
K. Sircar, S. Yoo, Tadeusz Majewski, K. Wani, Lalit Patel, Horatiu Voicu, Wandaliz Torres-García, R. Verhaak, N. Tannir, J. Karam, E. Jonasch, C. Wood, P. Tamboli, K. Baggerly, K. Aldape, B. Czerniak (2015)
Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non‐sarcomatoid renal carcinomasThe Journal of Pathology: Clinical Research, 1
-
G. Malouf, Siraj Ali, Kai Wang, S. Balasubramanian, J. Ross, V. Miller, P. Stephens, D. Khayat, S. Pal, X. Su, K. Sircar, P. Tamboli, E. Jonasch, N. Tannir, C. Wood, J. Karam (2016)
Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.European urology, 70 2
-
M. Amin, M. Amin, P. Tamboli, J. Javidan, H. Stricker, M. Venturina, A. Deshpande, M. Menon (2002)
Prognostic Impact of Histologic Subtyping of Adult Renal Epithelial Neoplasms: An Experience of 405 CasesThe American Journal of Surgical Pathology, 26
-
V. Trudeau, A. Larcher, M. Sun, K. Boehm, P. Dell’Oglio, José Sosa, Z. Tian, N. Fossati, A. Briganti, S. Shariat, P. Karakiewicz (2016)
Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinomaWorld Journal of Urology, 34
-
A. Ravaud, R. Motzer, H. Pandha, D. George, A. Pantuck, Anup Patel, Yen‐Hwa Chang, B. Escudier, F. Donskov, A. Magheli, G. Cartenì, B. Laguerre, P. Tomczak, J. Breza, P. Gerletti, M. Lechuga, Xun Lin, J. Martini, K. Ramaswamy, M. Casey, M. Staehler, J. Patard (2016)
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.The New England journal of medicine, 375 23
-
A. Maiti, Maryam Nemati-Shafaee, P. Msaouel, L. Pagliaro, E. Jonasch, N. Tannir, A. Shah (2017)
Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal‐Cell CarcinomaClinical Genitourinary Cancer, 16
-
L. Gu, Hong-zhao Li, Hanfeng Wang, Xin Ma, Lei Wang, Luyao Chen, Wenlei Zhao, Yu Zhang, Xu Zhang (2017)
Presence of sarcomatoid differentiation as a prognostic indicator for survival in surgically treated metastatic renal cell carcinomaJournal of Cancer Research and Clinical Oncology, 143
-
K. Rouvinov, L. Osyntsov, R. Shaco-levy, Nina Baram, S. Ariad, W. Mermershtain (2017)
Rapid Response to Nivolumab in a Patient With Sarcomatoid Transformation of Chromophobe Renal Cell CarcinomaClinical Genitourinary Cancer, 15
-
D. Geynisman (2015)
Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features.European urology, 68 5
-
M. Merrill, C. Wood, N. Tannir, R. Slack, K. Babaian, E. Jonasch, L. Pagliaro, Zachary Compton, P. Tamboli, K. Sircar, L. Pisters, S. Matin, J. Karam (2015)
Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent.Urologic oncology, 33 4
-
B. Mian, N. Bhadkamkar, J. Slaton, P. Pisters, D. Daliani, D. Swanson, L. Pisters (2002)
Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma.The Journal of urology, 167 1
-
J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J. Coebergh, H. Comber, D. Forman, F. Bray (2013)
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.European journal of cancer, 49 6
-
V. Kunene, M. Miscoria, S. Pirrie, M. Islam, M. Afshar, E. Porfiri (2014)
Sarcomatoid renal cell carcinoma: clinical outcome and survival after treatment with sunitinib.Clinical genitourinary cancer, 12 4
-
C. Kyriakopoulos, N. Chittoria, T. Choueiri, N. Kroeger, Jae-Lyun Lee, S. Srinivas, J. Knox, G. Bjarnason, S. Ernst, L. Wood, U. Vaishampayan, N. Agarwal, S. Pal, R. Kanesvaran, S. Rha, T. Yuasa, F. Donskov, S. North, D. Heng, B. Rini (2015)
Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.Clinical genitourinary cancer, 13 2
-
T. Jones, J. Eble, Mingsheng Wang, G. MacLennan, S. Jain, Liang Cheng (2005)
Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformationCancer, 104
-
Okyaz Eminaga, I. Akbarov, S. Wille, U. Engelmann (2015)
Does postoperative radiation therapy impact survival in non-metastatic sarcomatoid renal cell carcinoma? A SEER-based studyInternational Urology and Nephrology, 47
-
Yusheng Wang, Weibing Shuang, Keqiang Yin, Xu-nan Tong, Mancheng Xia, Haosen Yang (2019)
Analysis of the factors influencing the survival time of patients with sarcomatoid renal cell carcinoma.Molecular and clinical oncology, 11 4
-
S. Pal, M. He, Tommy Tong, Huiqing Wu, Xueli Liu, C. Lau, Jinhui Wang, C. Warden, Xiwei Wu, S. Signoretti, T. Choueiri, J. Karam, Jeremy Jones (2014)
RNA-seq Reveals Aurora Kinase–Driven mTOR Pathway Activation in Patients with Sarcomatoid Metastatic Renal Cell CarcinomaMolecular Cancer Research, 13
-
H. Visapää, D. Seligson, Yunda Huang, J. Rao, A. Belldegrun, S. Horvath, A. Palotie (2003)
Ki67, gelsolin and PTEN expression in sarcomatoid renal tumorsUrological Research, 30
-
P. Bergerot, N. Agarwal, S. Pal, Jeremy Jones (2017)
Sarcomatoid Renal Cell Carcinoma: The Apple Doesn't Fall Far from the TreeClinical Cancer Research, 23
-
M. Michaelson, R. McKay, L. Werner, M. Atkins, E. Allen, Kara Olivier, Jiaxi Song, S. Signoretti, D. McDermott, T. Choueiri (2015)
Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor‐risk metastatic renal cell carcinomaCancer, 121
-
S. Keskin, P. Msaouel, K. Hess, Kai-Jie Yu, S. Matin, K. Sircar, P. Tamboli, E. Jonasch, C. Wood, J. Karam, N. Tannir (2017)
Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy ErasThe Journal of Urology, 198
-
R. Joseph, S. Millis, E. Carballido, D. Bryant, Z. Gatalica, S. Reddy, A. Bryce, N. Vogelzang, M. Stanton, E. Castle, T. Ho (2015)
PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid DifferentiationCancer Immunology Research, 3
-
Ozlem Isikci, H. He, P. Grossmann, R. Alaghehbandan, M. Ulamec, Květoslava Michalová, K. Pivovarcikova, D. Montiel, O. Ondič, O. Daum, K. Procházková, M. Hora, M. Michal, O. Hes (2018)
Low‐grade spindle cell proliferation in clear cell renal cell carcinoma is unlikely to be an initial step in sarcomatoid differentiationHistopathology, 72
-
C. Kwak, Yongjin Park, C. Jeong, Hyeon Jeong, Sang Lee, K. Moon, J. Ku (2007)
Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinomaJournal of Surgical Oncology, 95
-
J. Patard, Hyung Kim, J. Lam, F. Dorey, A. Pantuck, A. Zisman, V. Ficarra, Ken‐ryu Han, L. Cindolo, A. taille, J. Tostain, W. Artibani, C. Dinney, C. Wood, D. Swanson, C. Abbou, B. Lobel, P. Mulders, D. Chopin, R. Figlin, A. Belldegrun (2004)
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 16
-
B. Delahunt, J. Cheville, G. Martignoni, P. Humphrey, C. Magi-Galluzzi, J. McKenney, L. Egevad, F. Algaba, H. Moch, D. Grignon, R. Montironi, J. Srigley (2013)
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic ParametersThe American Journal of Surgical Pathology, 37
-
B. Shuch, G. Bratslavsky, J. Shih, S. Vourganti, D. Finley, B. Castor, Eric Treat, W. Linehan, A. Pantuck, J. Said, A. Belldegrun (2012)
Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinomaBJU International, 109
-
B. Shuch, J. Said, J. Larochelle, Ying Zhou, Gang Li, T. Klatte, F. Pouliot, F. Kabbinavar, A. Belldegrun, A. Pantuck (2010)
Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapyCancer, 116
-
(2017)
Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma -
J. Dutcher, D. Nanus (2011)
Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapyMedical Oncology, 28
-
Joseph Sanfrancesco, J. Eble, D. Grignon, Mingsheng Wang, Shaobo Zhang, C. Sundaram, Muhammad Idrees, R. Pili, E. Kouba, Liang Cheng (2017)
Preservation of truncal genomic alterations in clear cell and papillary renal cell carcinomas with sarcomatoid features: An intra‐ and intertumoral, multifocal fluorescence in situ hybridization analysis reveals limited genetic heterogeneityMolecular Carcinogenesis, 56
-
U. Capitanio, B. Leibovich (2017)
The rationale and the role of lymph node dissection in renal cell carcinomaWorld Journal of Urology, 35
-
M. Voss, D. Bastos, C. Karlo, A. Ajeti, A. Hakimi, D. Feldman, J. Hsieh, A. Molina, S. Patil, R. Motzer (2014)
Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies.Annals of oncology : official journal of the European Society for Medical Oncology, 25 3
-
D. Nguyen, A. Vilaseca, E. Vertosick, R. Corradi, K. Touijer, N. Benfante, D. Sjoberg, P. Russo (2016)
Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgicallyWorld Journal of Urology, 34
-
Hyung Kim, A. Belldegrun, D. Freitas, M. Bui, Ken‐ryu Han, F. Dorey, R. Figlin (2003)
Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis.The Journal of urology, 170 5
-
S. Culine, M. Békradda, M. Terrier-Lacombe, J. Droz (1995)
Treatment of sarcomatoid renal cell carcinoma: is there a role for chemotherapy?European urology, 27 2
-
J. Cheville, C. Lohse, H. Zincke, A. Weaver, B. Leibovich, I. Frank, M. Blute (2004)
Sarcomatoid Renal Cell Carcinoma: An Examination of Underlying Histologic Subtype and an Analysis of Associations With Patient OutcomeThe American Journal of Surgical Pathology, 28
-
J. Young, Jocelyn Young, D. Margolis, S. Sauk, J. Sayre, A. Pantuck, S. Raman (2017)
Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT.Academic radiology, 24 10
-
Wenjuan Yu, Yuewei Wang, Yan-xia Jiang, Wei Zhang, Yujun Li (2017)
Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 casesBMC Cancer, 17
-
R. Motzer, A. Ravaud, J. Patard, H. Pandha, D. George, Anup Patel, Yen‐Hwa Chang, B. Escudier, F. Donskov, A. Magheli, G. Cartenì, B. Laguerre, P. Tomczak, J. Breza, P. Gerletti, M. Lechuga, Xun Lin, M. Casey, L. Serfass, A. Pantuck, M. Staehler (2018)
Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results.European urology, 73 1
-
R. Mano, J. Flynn, Kyle Blum, A. Silagy, R. DiNatale, J. Marcon, Alan Wang, Alejandro Sanchez, J. Coleman, P. Russo, I. Ostrovnaya, A. Hakimi (2019)
The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma.Urologic oncology
-
T. Cangiano, Joseph Liao, J. Naitoh, F. Dorey, R. Figlin, A. Belldegrun (1999)
Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 2
-
Tala Achkar, A. Arjunan, Hong Wang, M. Saul, D. Davar, L. Appleman, D. Friedland, Rahul Parikh (2017)
High-dose interleukin 2 in patients with metastatic renal cell carcinoma with sarcomatoid featuresPLoS ONE, 12
-
N. Kuroda, M. Toi, Masayuki Hiroi, H. Enzan (2003)
Review of sarcomatoid renal cell carcinoma with focus on clinical and pathobiological aspects.Histology and histopathology, 18 2
-
M. Bi, Siming Zhao, J. Said, M. Merino, Adebowale Adeniran, Zuoquan Xie, Cayce Nawaf, Jaehyuk Choi, A. Belldegrun, A. Pantuck, H. Kluger, Kaya Bilgüvar, R. Lifton, B. Shuch (2016)
Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinomaProceedings of the National Academy of Sciences, 113
-
A. Warren, D. Harrison (2018)
WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversiesWorld Journal of Urology, 36
-
M. Castillo, A. Petit, B. Mellado, A. Palacín, J. Alcover, C. Mallofré (2004)
C-kit expression in sarcomatoid renal cell carcinoma: potential therapy with imatinib.The Journal of urology, 171 6 Pt 1
-
Zixing Wang, Tae Kim, Bo Peng, J. Karam, C. Creighton, Aron Joon, F. Kawakami, P. Trevisan, E. Jonasch, C. Chow, J. Canales, P. Tamboli, N. Tannir, C. Wood, F. Monzon, K. Baggerly, M. Varella-Garcia, B. Czerniak, I. Wistuba, G. Mills, K. Shaw, Ken Chen, K. Sircar (2017)
Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional LandscapeClinical Cancer Research, 23
-
D. McDermott, J. Sosman, M. Sznol, C. Massard, M. Gordon, O. Hamid, J. Powderly, J. Infante, M. Fassò, Yan Wang, W. Zou, P. Hegde, G. Fine, T. Powles (2016)
Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 8
-
H. Moch, A. Cubilla, P. Humphrey, V. Reuter, T. Ulbright (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.European urology, 70 1
-
M. Gerlinger, S. Horswell, J. Larkin, A. Rowan, M. Salm, I. Varela, R. Fisher, N. Mcgranahan, N. Matthews, Claudio Santos, P. Martinez, B. Phillimore, Sharmin Begum, Adam Rabinowitz, B. Spencer‐Dene, Sakshi Gulati, P. Bates, G. Stamp, L. Pickering, M. Gore, D. Nicol, S. Hazell, P. Futreal, A. Stewart, C. Swanton (2014)
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencingNature Genetics, 46
-
A. Molina, S. Tickoo, N. Ishill, M. Trinos, L. Schwartz, S. Patil, D. Feldman, V. Reuter, P. Russo, R. Motzer (2011)
Sarcomatoid-variant Renal Cell Carcinoma: Treatment Outcome and Survival in Advanced DiseaseAmerican Journal of Clinical Oncology, 34
-
B. Leibovich, M. Blute, J. Cheville, C. Lohse, I. Frank, E. Kwon, A. Weaver, A. Parker, H. Zincke (2003)
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinomaCancer, 97
-
B. Escudier, J. Droz, F. Rolland, M. Terrier-Lacombe, G. Gravis, P. Beuzeboc, B. Chauvet, C. Chevreau, J. Eymard, T. Lesimple, Y. Merrouche, S. Oudard, F. Priou, C. Guillemare, S. Gourgou, S. Culine (2002)
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers.The Journal of urology, 168 3
-
Arun Thomas, M. Adibi, R. Slack, Leonardo Borregales, M. Merrill, P. Tamboli, K. Sircar, E. Jonasch, N. Tannir, S. Matin, C. Wood, J. Karam (2016)
The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis.The Journal of urology, 196 3
-
N. Haas, Xinyi Lin, J. Manola, M. Pins, Glenn Liu, D. McDermott, D. Nanus, E. Heath, G. Wilding, J. Dutcher (2012)
A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802Medical Oncology, 29
-
M. Peralta-Venturina, H. Moch, M. Amin, P. Tamboli, S. Hailemariam, Michael Mihatsch, J. Javidan, H. Stricker, J. Ro, M. Amin (2001)
Sarcomatoid Differentiation in Renal Cell Carcinoma: A Study of 101 CasesThe American Journal of Surgical Pathology, 25
-
R. Pichler, E. Compérat, T. Klatte, M. Pichler, W. Loidl, L. Lusuardi, M. Schmidinger (2019)
Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?Cancers, 11
-
R. Kalluri, R. Weinberg (2009)
The basics of epithelial-mesenchymal transition.The Journal of clinical investigation, 119 6
-
U. Capitanio, Vincent Cloutier, L. Zini, H. Isbarn, C. Jeldres, S. Shariat, P. Perrotte, E. Antebi, J. Patard, F. Montorsi, P. Karakiewicz (2009)
A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population‐based studyBJU International, 103
-
A. Silagy, R. Mano, Kyle Blum, R. DiNatale, J. Marcon, S. Tickoo, E. Reznik, J. Coleman, P. Russo, A. Hakimi (2019)
The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-year Institutional Experience.Urology
-
A. Golshayan, S. George, D. Heng, P. Elson, L. Wood, T. Mekhail, Jorge Garcia, H. Aydın, Ming Zhou, R. Bukowski, B. Rini (2009)
Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 2
-
P. Crispen, S. Boorjian, C. Lohse, T. Sebo, J. Cheville, M. Blute, B. Leibovich (2008)
Outcomes following partial nephrectomy by tumor size.The Journal of urology, 180 5
-
B. Shuch, J. Said, Jeffrey Rochelle, Ying Zhou, Gang Li, T. Klatte, Fairooz Kabbinaavar, A. Pantuck, A. Belldegrun (2009)
Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?The Journal of urology, 182 5
-
BC Leibovich, ML Blute, JC Cheville (2003)
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trialsCancer, 97
- Publisher
- Springer Journals
- Copyright
- Copyright © 2018 by Springer-Verlag GmbH Germany, part of Springer Nature
- Subject
- Medicine & Public Health; Urology; Nephrology; Oncology
- ISSN
- 0724-4983
- eISSN
- 1433-8726
- DOI
- 10.1007/s00345-018-2355-y
- Publisher site
- See Article on Publisher Site
Abstract
Long recognized to confer an extremely poor prognosis, sarcomatoid dedifferentiation of renal cell carcinoma (sRCC) is a tumor phenotype that is finally beginning to be better understood on the molecular and genetic levels. With an overall incidence that ranges from 1 to 32% depending on associated RCC subtype, the survival of sarcomatoid RCC patients rarely exceeds 2 years. The main reasons for its poor outcome include its aggressive biology, its tendency to present at an advanced or metastatic stage at the time of diagnosis, its high rate of tumor recurrence after nephrectomy, and its limited response to systemic therapies. Molecular pathology studies suggest that sarcomatoid dedifferentiation originates from a focal epithelial–mesenchymal transition (EMT) arising in the carcinomatous component of the tumor. It is hoped that the growing understanding of the molecular biology of sRCC will soon make it possible to adapt treatments based on the identification of actionable tumor alterations. The deliberate inclusion of these patients in the multicenter clinical trials of immune, targeted and combination therapies is a necessary next step in pioneering future treatment strategies.
Journal
World Journal of Urology – Springer Journals
Published: Jun 1, 2018